A procedure for preparing nucleosides and analogues of nucleosides

Procedure for preparing nucleosides and analogues of nucleosides of the formula where A is X is O, S or CH2; R1 is H, alkyl of 1-3 carbons, -CH=CH2, -CH=CH-CH3, -CH2-CH=CH2, or -C[triple bond]CH; R2 is H or constitutes a carbon-carbon bond together with R3; and R3 is H, halogen, N3, CN, C=CH, OH, OC...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: STENING GORAN BERTIL, DATEMA ROELF, KOVACS ZSUZSANNA M I, JOHANSSON KARL NILS GUNNA, OBERG BO FREDRIK, LINDBORG BJORN GUNNAR
Format: Patent
Sprache:eng ; spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator STENING GORAN BERTIL
DATEMA ROELF
KOVACS ZSUZSANNA M I
JOHANSSON KARL NILS GUNNA
OBERG BO FREDRIK
LINDBORG BJORN GUNNAR
description Procedure for preparing nucleosides and analogues of nucleosides of the formula where A is X is O, S or CH2; R1 is H, alkyl of 1-3 carbons, -CH=CH2, -CH=CH-CH3, -CH2-CH=CH2, or -C[triple bond]CH; R2 is H or constitutes a carbon-carbon bond together with R3; and R3 is H, halogen, N3, CN, C=CH, OH, OCH3 or CH2OH, with R3 being able to have a cis or trans configuration, relative to the hydroxymethyl function, or with R3 constituting a carbon-carbon bond together with R2. This procedure involves condensing a glycoside included in formula I in the N-1 position of a pyrimidine derivative corresponding to an aforesaid radical A, separating the α-anomer of the compound I formed and eliminating any protecting group present. There are other methods of preparation which are described in the specification. The compounds obtained are useful for preventing and treating hepatitis B, AIDS and other infections in mammals. PROCEDIMIENTO PARA PREPARAR NUCLEOSIDOS Y ANALOGOS DE NUCLEOSIDOS DE FORMULA DONDE A ES X ES O, S O CH2; R1 ES HIDROGENO, ALQUILO DE 1-3 CARBONOS, -CH=CH2, -CH=CH-CH3, -CH2-CH=CH2, -C-=CH2-CH3 O -C=CH; R2 ES H O CONSTITUYE JUNTO CON R3 UN ENLACE CARBONO-CARBONO; Y R3 ES H, HALOGENO, N3, CN, C=CH, OH, OCH3 O CH2OH, PUDIENDO TENER R3 CONFIGURACION CIS O TRANS, CON RELACION A LA FUNCION HIDROXIMETILO O CONSTITUYENDO R3 JUNTO CON R2 UN ENLACE CARBONO-CARBONO. ESTE PROCEDIMIENTO COMPRENDE CONDENSAR UN GLICOSIDO INCLUIDO EN LA FORMULA (I) EN LA POSICION N-1 DE UN DERIVADO DE PIRIMIDINA CORRESPONDIENTE A UN RADICAL A ANTES CITADO, SEPARAR EL ANOMERO DEL COMPUESTO (I) FORMADO Y ELIMINAR CUALQUIER GRUPO PROTECTOR PRESENTE. EXISTEN OTRAS VIAS DE PREPARACION QUE SE DESCRIBEN EN LA MEMORIA. LOS COMPUESTOS OBTENIDOS SON UTILES PARA PREVENIR Y TRATAR HEPATITIS B, SIDA Y OTRAS INFECCIONES EN MAMIFEROS.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ES2013350A6</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ES2013350A6</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ES2013350A63</originalsourceid><addsrcrecordid>eNrjZHByVCgoyk9OTSktSlVIyy8C8lILEosy89IV8kqTc1LzizNTUosVEvNSgDgxJz-9FMjLT0OW5GFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a7BRgaGxsamBo5mxkQoAQDwBTHZ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>A procedure for preparing nucleosides and analogues of nucleosides</title><source>esp@cenet</source><creator>STENING GORAN BERTIL ; DATEMA ROELF ; KOVACS ZSUZSANNA M I ; JOHANSSON KARL NILS GUNNA ; OBERG BO FREDRIK ; LINDBORG BJORN GUNNAR</creator><creatorcontrib>STENING GORAN BERTIL ; DATEMA ROELF ; KOVACS ZSUZSANNA M I ; JOHANSSON KARL NILS GUNNA ; OBERG BO FREDRIK ; LINDBORG BJORN GUNNAR</creatorcontrib><description>Procedure for preparing nucleosides and analogues of nucleosides of the formula where A is X is O, S or CH2; R1 is H, alkyl of 1-3 carbons, -CH=CH2, -CH=CH-CH3, -CH2-CH=CH2, or -C[triple bond]CH; R2 is H or constitutes a carbon-carbon bond together with R3; and R3 is H, halogen, N3, CN, C=CH, OH, OCH3 or CH2OH, with R3 being able to have a cis or trans configuration, relative to the hydroxymethyl function, or with R3 constituting a carbon-carbon bond together with R2. This procedure involves condensing a glycoside included in formula I in the N-1 position of a pyrimidine derivative corresponding to an aforesaid radical A, separating the α-anomer of the compound I formed and eliminating any protecting group present. There are other methods of preparation which are described in the specification. The compounds obtained are useful for preventing and treating hepatitis B, AIDS and other infections in mammals. PROCEDIMIENTO PARA PREPARAR NUCLEOSIDOS Y ANALOGOS DE NUCLEOSIDOS DE FORMULA DONDE A ES X ES O, S O CH2; R1 ES HIDROGENO, ALQUILO DE 1-3 CARBONOS, -CH=CH2, -CH=CH-CH3, -CH2-CH=CH2, -C-=CH2-CH3 O -C=CH; R2 ES H O CONSTITUYE JUNTO CON R3 UN ENLACE CARBONO-CARBONO; Y R3 ES H, HALOGENO, N3, CN, C=CH, OH, OCH3 O CH2OH, PUDIENDO TENER R3 CONFIGURACION CIS O TRANS, CON RELACION A LA FUNCION HIDROXIMETILO O CONSTITUYENDO R3 JUNTO CON R2 UN ENLACE CARBONO-CARBONO. ESTE PROCEDIMIENTO COMPRENDE CONDENSAR UN GLICOSIDO INCLUIDO EN LA FORMULA (I) EN LA POSICION N-1 DE UN DERIVADO DE PIRIMIDINA CORRESPONDIENTE A UN RADICAL A ANTES CITADO, SEPARAR EL ANOMERO DEL COMPUESTO (I) FORMADO Y ELIMINAR CUALQUIER GRUPO PROTECTOR PRESENTE. EXISTEN OTRAS VIAS DE PREPARACION QUE SE DESCRIBEN EN LA MEMORIA. LOS COMPUESTOS OBTENIDOS SON UTILES PARA PREVENIR Y TRATAR HEPATITIS B, SIDA Y OTRAS INFECCIONES EN MAMIFEROS.</description><edition>4</edition><language>eng ; spa</language><subject>CHEMISTRY ; CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION ORPROCESSING OF GOODS ; DERIVATIVES THEREOF ; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC ; GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SUGARS ; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS ; TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE</subject><creationdate>1990</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19900501&amp;DB=EPODOC&amp;CC=ES&amp;NR=2013350A6$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19900501&amp;DB=EPODOC&amp;CC=ES&amp;NR=2013350A6$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>STENING GORAN BERTIL</creatorcontrib><creatorcontrib>DATEMA ROELF</creatorcontrib><creatorcontrib>KOVACS ZSUZSANNA M I</creatorcontrib><creatorcontrib>JOHANSSON KARL NILS GUNNA</creatorcontrib><creatorcontrib>OBERG BO FREDRIK</creatorcontrib><creatorcontrib>LINDBORG BJORN GUNNAR</creatorcontrib><title>A procedure for preparing nucleosides and analogues of nucleosides</title><description>Procedure for preparing nucleosides and analogues of nucleosides of the formula where A is X is O, S or CH2; R1 is H, alkyl of 1-3 carbons, -CH=CH2, -CH=CH-CH3, -CH2-CH=CH2, or -C[triple bond]CH; R2 is H or constitutes a carbon-carbon bond together with R3; and R3 is H, halogen, N3, CN, C=CH, OH, OCH3 or CH2OH, with R3 being able to have a cis or trans configuration, relative to the hydroxymethyl function, or with R3 constituting a carbon-carbon bond together with R2. This procedure involves condensing a glycoside included in formula I in the N-1 position of a pyrimidine derivative corresponding to an aforesaid radical A, separating the α-anomer of the compound I formed and eliminating any protecting group present. There are other methods of preparation which are described in the specification. The compounds obtained are useful for preventing and treating hepatitis B, AIDS and other infections in mammals. PROCEDIMIENTO PARA PREPARAR NUCLEOSIDOS Y ANALOGOS DE NUCLEOSIDOS DE FORMULA DONDE A ES X ES O, S O CH2; R1 ES HIDROGENO, ALQUILO DE 1-3 CARBONOS, -CH=CH2, -CH=CH-CH3, -CH2-CH=CH2, -C-=CH2-CH3 O -C=CH; R2 ES H O CONSTITUYE JUNTO CON R3 UN ENLACE CARBONO-CARBONO; Y R3 ES H, HALOGENO, N3, CN, C=CH, OH, OCH3 O CH2OH, PUDIENDO TENER R3 CONFIGURACION CIS O TRANS, CON RELACION A LA FUNCION HIDROXIMETILO O CONSTITUYENDO R3 JUNTO CON R2 UN ENLACE CARBONO-CARBONO. ESTE PROCEDIMIENTO COMPRENDE CONDENSAR UN GLICOSIDO INCLUIDO EN LA FORMULA (I) EN LA POSICION N-1 DE UN DERIVADO DE PIRIMIDINA CORRESPONDIENTE A UN RADICAL A ANTES CITADO, SEPARAR EL ANOMERO DEL COMPUESTO (I) FORMADO Y ELIMINAR CUALQUIER GRUPO PROTECTOR PRESENTE. EXISTEN OTRAS VIAS DE PREPARACION QUE SE DESCRIBEN EN LA MEMORIA. LOS COMPUESTOS OBTENIDOS SON UTILES PARA PREVENIR Y TRATAR HEPATITIS B, SIDA Y OTRAS INFECCIONES EN MAMIFEROS.</description><subject>CHEMISTRY</subject><subject>CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION ORPROCESSING OF GOODS</subject><subject>DERIVATIVES THEREOF</subject><subject>GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC</subject><subject>GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SUGARS</subject><subject>TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS</subject><subject>TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1990</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHByVCgoyk9OTSktSlVIyy8C8lILEosy89IV8kqTc1LzizNTUosVEvNSgDgxJz-9FMjLT0OW5GFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a7BRgaGxsamBo5mxkQoAQDwBTHZ</recordid><startdate>19900501</startdate><enddate>19900501</enddate><creator>STENING GORAN BERTIL</creator><creator>DATEMA ROELF</creator><creator>KOVACS ZSUZSANNA M I</creator><creator>JOHANSSON KARL NILS GUNNA</creator><creator>OBERG BO FREDRIK</creator><creator>LINDBORG BJORN GUNNAR</creator><scope>EVB</scope></search><sort><creationdate>19900501</creationdate><title>A procedure for preparing nucleosides and analogues of nucleosides</title><author>STENING GORAN BERTIL ; DATEMA ROELF ; KOVACS ZSUZSANNA M I ; JOHANSSON KARL NILS GUNNA ; OBERG BO FREDRIK ; LINDBORG BJORN GUNNAR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ES2013350A63</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>1990</creationdate><topic>CHEMISTRY</topic><topic>CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION ORPROCESSING OF GOODS</topic><topic>DERIVATIVES THEREOF</topic><topic>GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC</topic><topic>GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SUGARS</topic><topic>TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS</topic><topic>TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE</topic><toplevel>online_resources</toplevel><creatorcontrib>STENING GORAN BERTIL</creatorcontrib><creatorcontrib>DATEMA ROELF</creatorcontrib><creatorcontrib>KOVACS ZSUZSANNA M I</creatorcontrib><creatorcontrib>JOHANSSON KARL NILS GUNNA</creatorcontrib><creatorcontrib>OBERG BO FREDRIK</creatorcontrib><creatorcontrib>LINDBORG BJORN GUNNAR</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>STENING GORAN BERTIL</au><au>DATEMA ROELF</au><au>KOVACS ZSUZSANNA M I</au><au>JOHANSSON KARL NILS GUNNA</au><au>OBERG BO FREDRIK</au><au>LINDBORG BJORN GUNNAR</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>A procedure for preparing nucleosides and analogues of nucleosides</title><date>1990-05-01</date><risdate>1990</risdate><abstract>Procedure for preparing nucleosides and analogues of nucleosides of the formula where A is X is O, S or CH2; R1 is H, alkyl of 1-3 carbons, -CH=CH2, -CH=CH-CH3, -CH2-CH=CH2, or -C[triple bond]CH; R2 is H or constitutes a carbon-carbon bond together with R3; and R3 is H, halogen, N3, CN, C=CH, OH, OCH3 or CH2OH, with R3 being able to have a cis or trans configuration, relative to the hydroxymethyl function, or with R3 constituting a carbon-carbon bond together with R2. This procedure involves condensing a glycoside included in formula I in the N-1 position of a pyrimidine derivative corresponding to an aforesaid radical A, separating the α-anomer of the compound I formed and eliminating any protecting group present. There are other methods of preparation which are described in the specification. The compounds obtained are useful for preventing and treating hepatitis B, AIDS and other infections in mammals. PROCEDIMIENTO PARA PREPARAR NUCLEOSIDOS Y ANALOGOS DE NUCLEOSIDOS DE FORMULA DONDE A ES X ES O, S O CH2; R1 ES HIDROGENO, ALQUILO DE 1-3 CARBONOS, -CH=CH2, -CH=CH-CH3, -CH2-CH=CH2, -C-=CH2-CH3 O -C=CH; R2 ES H O CONSTITUYE JUNTO CON R3 UN ENLACE CARBONO-CARBONO; Y R3 ES H, HALOGENO, N3, CN, C=CH, OH, OCH3 O CH2OH, PUDIENDO TENER R3 CONFIGURACION CIS O TRANS, CON RELACION A LA FUNCION HIDROXIMETILO O CONSTITUYENDO R3 JUNTO CON R2 UN ENLACE CARBONO-CARBONO. ESTE PROCEDIMIENTO COMPRENDE CONDENSAR UN GLICOSIDO INCLUIDO EN LA FORMULA (I) EN LA POSICION N-1 DE UN DERIVADO DE PIRIMIDINA CORRESPONDIENTE A UN RADICAL A ANTES CITADO, SEPARAR EL ANOMERO DEL COMPUESTO (I) FORMADO Y ELIMINAR CUALQUIER GRUPO PROTECTOR PRESENTE. EXISTEN OTRAS VIAS DE PREPARACION QUE SE DESCRIBEN EN LA MEMORIA. LOS COMPUESTOS OBTENIDOS SON UTILES PARA PREVENIR Y TRATAR HEPATITIS B, SIDA Y OTRAS INFECCIONES EN MAMIFEROS.</abstract><edition>4</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; spa
recordid cdi_epo_espacenet_ES2013350A6
source esp@cenet
subjects CHEMISTRY
CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION ORPROCESSING OF GOODS
DERIVATIVES THEREOF
GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SUGARS
TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE
title A procedure for preparing nucleosides and analogues of nucleosides
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T06%3A12%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=STENING%20GORAN%20BERTIL&rft.date=1990-05-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EES2013350A6%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true